Genomic structural variation in patients with Multiple Sclerosis

Key Points

• Structural variation in genomic data identifies potential biomarkers for multiple sclerosis.
• Key evidence indicates a significant correlation between genomic alterations and disease severity.
• Analysis involved comprehensive genetic assessment of patients diagnosed with multiple sclerosis.
• Findings may indicate new avenues for targeted therapies and early interventions in multiple sclerosis.